Our Pricing

Buy Cheapest Mounjaro Injections Online UK

Published on: June 03, 2026

Finding the cheapest Mounjaro injections online UK doesn't mean compromising on quality or safety. At Cured Pharmacy, we offer genuine UK-licensed Mounjaro (tirzepatide) KwikPens from £124.99 with transparent upfront pricing, free clinical consultations completed in under three minutes, and discreet next-day delivery across the UK.

Why Mounjaro Is the Most Effective Weight Loss Injection Available in the UK

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide or liraglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing superior metabolic effects and appetite regulation.

In the landmark SURPASS-3 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — significantly outperforming semaglutide 1mg in head-to-head comparisons [1][2]. The dual-receptor mechanism also demonstrated better glycaemic control and cardiovascular risk marker improvements compared to single-agonist therapies.

Clinical experience across our prescriber network shows that patients typically notice reduced appetite within the first week of treatment, with progressive weight loss becoming evident from week four onwards. The once-weekly injection schedule offers greater convenience than daily alternatives, supporting long-term adherence to treatment programmes.

Transparent Mounjaro Pricing: What You'll Actually Pay at Cured Pharmacy

At Cured Pharmacy, Mounjaro injections start from £124.99 for the 2.5mg starter dose, with all pricing displayed upfront before you begin your clinical assessment. This transparent approach means no hidden consultation fees, no surprise charges at checkout, and no pressure to commit before knowing the total cost.

Your final price depends on the maintenance dose your UK prescriber determines is clinically appropriate based on your medical history, current medications, weight loss goals, and response to initial treatment. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription is dispensed only after thorough clinical review, maintaining the highest standards of patient safety whilst offering competitive UK pricing.

We guarantee the lowest prices in the UK market for genuine, MHRA-licensed Mounjaro. If you find a lower advertised price from another UK-registered pharmacy for the same dose, we'll match it — because access to effective weight management shouldn't be limited by cost barriers.

What's Included in Your Mounjaro Service

Every Mounjaro prescription from Cured Pharmacy includes a free online consultation with a UK-registered prescriber, discreet packaging with no external branding, next-day delivery to any UK address, and ongoing clinical support throughout your treatment journey. There are no recurring subscription fees or mandatory follow-up charges — you only pay for the medication you need, when you need it.

How to Buy Mounjaro Online Safely: The Clinical Assessment Process

Mounjaro is a prescription-only medicine in the UK, which means it can only be supplied following a clinical assessment by a qualified prescriber. At Cured Pharmacy, our streamlined online consultation takes under three minutes to complete and covers your medical history, current medications, weight management goals, and any contraindications.

Our UK-registered prescribers review every assessment individually — this isn't an automated approval system. They'll evaluate whether Mounjaro is clinically appropriate for you based on NICE guidance, which recommends GLP-1 receptor agonists for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities [3]. If Mounjaro isn't suitable, they may recommend alternative treatments or advise consultation with your GP.

Once approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration number 9012511), where it's dispensed and dispatched the same day for next-day delivery. You'll receive tracking information and can contact our clinical team at any point if you have questions about dosing, side effects, or treatment progression.

Who Cannot Take Mounjaro

Mounjaro is not suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy and breastfeeding. Your prescriber will assess your full medical history to ensure safe prescribing, and you should always disclose all current medications including over-the-counter products and supplements.

Mounjaro vs Wegovy vs Saxenda: Choosing the Right Weight Loss Injection

All three injectable treatments work through GLP-1 receptor pathways to reduce appetite and improve metabolic function, but they differ significantly in mechanism, efficacy, and dosing frequency. Understanding these differences helps you and your prescriber select the most appropriate option for your individual circumstances.

Mounjaro's dual GIP/GLP-1 action produces the highest average weight loss in clinical trials — up to 22.5% body weight reduction at 72 weeks [1]. Wegovy (semaglutide) demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [2], whilst Saxenda (liraglutide) achieved 8% average weight loss over 56 weeks in the SCALE trial [4]. However, individual responses vary considerably, and some patients respond better to single-agonist therapies.

Dosing schedules also differ: both Mounjaro and Wegovy are administered once weekly, whilst Saxenda requires daily injections. Weekly injections generally support better long-term adherence, though some patients prefer the flexibility of daily dosing to manage side effects more gradually. Your prescriber will discuss these factors during your consultation to identify the optimal treatment pathway.

Managing Side Effects: What to Expect When Starting Mounjaro

The most common side effects of Mounjaro are gastrointestinal and typically include nausea, diarrhoea, decreased appetite, vomiting, and constipation [1]. These effects are usually mild to moderate, occur most frequently during dose escalation, and diminish as your body adapts to treatment over several weeks.

In our clinical experience, starting with the lowest dose (2.5mg) and following the gradual escalation schedule significantly reduces the severity of gastrointestinal symptoms. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can further minimise discomfort. If side effects become problematic, your prescriber may slow the dose escalation or maintain you at a lower maintenance dose.

Serious side effects are rare but include pancreatitis, gallbladder disease, hypoglycaemia (especially if taking other diabetes medications), and acute kidney injury secondary to dehydration. You should contact a healthcare professional immediately if you experience severe abdominal pain, persistent vomiting, signs of dehydration, or allergic reactions. Our clinical team is available on (+44) 116 4646009 for urgent medication queries.

Tips for Minimising Nausea

To reduce nausea during the initial weeks, inject Mounjaro at the same time each week, preferably in the evening after a light meal. Avoid lying down immediately after eating, choose bland foods over rich or spicy options, and consider ginger tea or peppermint as natural nausea remedies. If symptoms persist beyond the first month, consult your prescriber about adjusting your escalation schedule.

Maximising Results: Combining Mounjaro with Lifestyle Changes

Whilst Mounjaro produces significant weight loss through appetite suppression and metabolic improvements, clinical trials consistently show that combining medication with structured lifestyle interventions produces superior long-term outcomes [1][3]. The medication creates a physiological foundation that makes sustainable behaviour changes more achievable.

NICE guidance recommends that GLP-1 treatments be prescribed alongside a reduced-calorie diet and increased physical activity programme [3]. This doesn't require extreme restriction — even modest calorie deficits of 500-750 kcal per day, combined with 150 minutes of moderate-intensity activity per week, significantly enhance weight loss and metabolic health markers when paired with Mounjaro.

Our prescribers can provide personalised guidance on realistic dietary adjustments and activity goals based on your current fitness level and medical history. Many patients find that Mounjaro's appetite-suppressing effects make it substantially easier to adhere to calorie targets without the constant hunger and cravings that typically undermine weight loss attempts. This synergy between pharmacological and behavioural interventions is what drives the impressive results seen in clinical practice.

Long-Term Weight Maintenance

Clinical data shows that continuing Mounjaro treatment supports sustained weight loss, whilst discontinuation often leads to weight regain [1]. Your prescriber will work with you to develop a long-term management plan that may include ongoing medication, gradual dose reduction, or transition to maintenance therapy. Regular monitoring of weight, metabolic markers, and treatment response ensures your plan evolves with your changing needs.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.